K
Kimford J. Meador
Researcher at Stanford University
Publications - 472
Citations - 24355
Kimford J. Meador is an academic researcher from Stanford University. The author has contributed to research in topics: Epilepsy & Epilepsy surgery. The author has an hindex of 84, co-authored 444 publications receiving 22316 citations. Previous affiliations of Kimford J. Meador include Comprehensive Epilepsy Center & McKnight Brain Institute.
Papers
More filters
Journal ArticleDOI
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Kimford J. Meador,Gus A. Baker,Nancy Browning,Jill Clayton-Smith,Deborah T. Combs-Cantrell,Morris J. Cohen,Laura A. Kalayjian,Andres M. Kanner,Joyce Liporace,Page B. Pennell,Michael Privitera,David W. Loring +11 more
TL;DR: In utero exposure to valproate, as compared with other commonly used antiepileptic drugs, is associated with an increased risk of impaired cognitive function at 3 years of age, and this finding supports a recommendation thatValproate not be used as a first-choice drug in women of childbearing potential.
Journal ArticleDOI
Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory.
Joyce A. Cramer,Kenneth Perrine,Orrin Devinsky,Lynda Bryant-Comstock,Kimford J. Meador,Bruce P. Hermann +5 more
TL;DR: The development of a questionnaire to assess health‐related quality of‐life in people with epilepsy and the process of cross‐cultural translations of the questionnaire are reported.
Journal ArticleDOI
Development of the Quality of Life in Epilepsy Inventory
Orrin Devinsky,Barbara G. Vickrey,Joyce A. Cramer,Kenneth Perrine,Bruce P. Hermann,Kimford J. Meador,Ron D. Hays,Ron D. Hays +7 more
TL;DR: Reliability and validity of an instrument to measure health‐related quality of life (HRQOL) in epilepsy showed that the epilepsy‐targeted factor and three of its four component scales were more sensitive to categorization of patients by severity of seizure frequency and type than scales tapping physical health, mental health, or cognitive function.
Journal ArticleDOI
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study
Kimford J. Meador,Gus A. Baker,Nancy Browning,Morris J. Cohen,Rebecca Bromley,Jill Clayton-Smith,Laura A. Kalayjian,Andres M. Kanner,Joyce Liporace,Page B. Pennell,Michael Privitera,David W. Loring +11 more
TL;DR: In this paper, the effects of commonly used antiepileptic drugs on cognitive outcomes in children up to 6 years of age were assessed with linear regression adjusted for maternal IQ and periconceptional folate.
Journal ArticleDOI
Rapid detection of major depression in epilepsy: a multicentre study
Frank Gilliam,John J. Barry,Bruce P. Hermann,Kimford J. Meador,Victoria Vahle,Andres M. Kanner +5 more
TL;DR: The NDDI-E could enable rapid detection and improve management of depression in epilepsy in accordance with internationally recognised guidelines and showed optimum sensitivity, specificity, and predictive power at a cut score of more than 15.